본문 바로가기
KERD
논문KCI 등재

The deubiquitinase UCHL3 mediates p300-dependent chemokine signaling in alveolar type II cells to promote pulmonary fibrosis

Park Moo Suk|Park Soo-Yeon|Lee Seunghyun|Kim Hyunsik|Kwon Jae-Hwan|Yoo Jung-Yoon|Yoon Ho-Geun|Kim Kyunggon|Lee Soo Yeon|Lee Chun-Geun|Elias Jack A.|Sohn Myung Hyun|Shim Hyo Sup
생화학분자생물학회 (Korean Society Of Biochemistry And Molecular Biology)|2023.12|Experimental and Molecular Medicine|제55권 |pp. 1795-1805|DOI 10.1038/s12276-023-01066-1

0

조회

0

다운로드

0

인용

0

참고문헌

주제분류생화학

초록

Idiopathic pulmonary fibrosis (IPF) is a chronic, fatal, fibrotic, interstitial lung disease of unknown cause. Despite extensive studies, the underlying mechanisms of IPF development remain unknown. Here, we found that p300 was upregulated in multiple epithelial cells in lung samples from patients with IPF and mouse models of lung fibrosis. Lung fibrosis was significantly diminished by the alveolar type II (ATII) cell–specific deletion of the p300 gene. Moreover, we found that ubiquitin C-terminal hydrolase L3 (UCHL3)-mediated deubiquitination of p300 led to the transcriptional activation of the chemokines Ccl2, Ccl7, and Ccl12 through the cooperative action of p300 and C/EBPβ, which consequently promoted M2 macrophage polarization. Selective blockade of p300 activity in ATII cells resulted in the reprogramming of M2 macrophages into antifibrotic macrophages. These findings demonstrate a pivotal role for p300 in the development of lung fibrosis and suggest that p300 could serve as a promising target for IPF treatment.

Abstract

Idiopathic pulmonary fibrosis (IPF) is a chronic, fatal, fibrotic, interstitial lung disease of unknown cause. Despite extensive studies, the underlying mechanisms of IPF development remain unknown. Here, we found that p300 was upregulated in multiple epithelial cells in lung samples from patients with IPF and mouse models of lung fibrosis. Lung fibrosis was significantly diminished by the alveolar type II (ATII) cell–specific deletion of the p300 gene. Moreover, we found that ubiquitin C-terminal hydrolase L3 (UCHL3)-mediated deubiquitination of p300 led to the transcriptional activation of the chemokines Ccl2, Ccl7, and Ccl12 through the cooperative action of p300 and C/EBPβ, which consequently promoted M2 macrophage polarization. Selective blockade of p300 activity in ATII cells resulted in the reprogramming of M2 macrophages into antifibrotic macrophages. These findings demonstrate a pivotal role for p300 in the development of lung fibrosis and suggest that p300 could serve as a promising target for IPF treatment.

참고문헌 (53)

  1. Lederer, D. J., "Idiopathic pulmonary fibrosis", N. Engl. J. Med, 378, pp.1811~1823 (2018)
  2. Kinoshita, T., "Molecular mechanisms of pulmonary fibrogenesis and its progression to lung cancer: a review", Int. J. Mol. Sci, 20 (2019)[DOI]
  3. Varone, F., "Nintedanib for the treatment of idiopathic pulmonary fibrosis", Expert Opin. Pharmacother, 19, pp.167~175 (2018)
  4. Maher, T. M., "Identifying barriers to idiopathic pulmonary fibrosis treatment : a survey of patient and physician views", Respiration, 96, pp.514~524 (2018)
  5. Chambers, R. C., "Mechanisms of alveolar epithelial injury, repair, and fibrosis", Ann. Am. Thorac. Soc, 12, pp.S16~S20 (2015)
  6. Olajuyin, A. M., "Alveolar type 2 progenitor cells for lung injury repair", Cell Death Discov, 5, pp.63~ (2019)
  7. Jansing, N. L., "Unbiased quantitation of alveolar Type II to alveolar type I cell transdifferentiation during repair after lung injury in mice", Am. J. Respir. Cell Mol. Biol, 57, pp.519~526 (2017)
  8. Hinz, B., "Formation and function of the myofibroblast during tissue repair", J. Invest. Dermatol, 127, pp.526~537 (2007)
  9. Serrano-Mollar, A., "Safety and tolerability of alveolar Type II cell transplantation in idiopathic pulmonary fibrosis", Chest, 150, pp.533~543 (2016)
  10. Watts, K. L., "Connective tissue growth factor expression and induction by transforming growth factor-beta is abrogated by simvastatin via a Rho signaling mechanism", Am. J. Physiol. Lung Cell Mol. Physiol, 287, pp.L1323~L1332 (2004)
  11. Bonniaud, P., "Connective tissue growth factor is crucial to inducing a profibrotic environment in"fibrosis-resistant"Balb", c mouse lungs, 2004, pp.31, 510~516
  12. Selman, M., "The leading role of epithelial cells in the pathogenesis of idiopathic pulmonary fibrosis", Cell Signal, 66, pp.109482~ (2020)
  13. Parimon, T., "Alveolar epithelial type II cells as drivers of lung fibrosis in idiopathic pulmonary fibrosis", Int. J. Mol. Sci, 21, pp.2269~ (2020)
  14. Helling, B. A., "Epigenetics in lung fibrosis : from pathobiology to treatment perspective", Curr. Opin. Pulm. Med, 21, pp.454~462 (2015)
  15. Yang, I. V., "Epigenetics of idiopathic pulmonary fibrosis", Transl. Res, 165, pp.48~60 (2015)
  16. Rosas, I. O., "The promise of epigenetic therapies in treatment of idiopathic pulmonary fibrosis", Am. J. Respir. Crit. Care Med, 187, pp.336~338 (2013)
  17. Korfei, M., "Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis", Thorax, 70, pp.1022~1032 (2015)
  18. Li, M., "Effects of dynamic changes in histone acetylation and deacetylase activity on pulmonary fibrosis", Int. Immunopharmacol, 52, pp.272~280 (2017)
  19. Sanders, Y. Y., "Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice", Eur. Respir J, 43, pp.1448~1458 (2014)
  20. Coward, W. R., "Defective histone acetylation is responsible for the diminished expression of Cyclooxygenase-2 in Idiopathic Pulmonary Fibrosis", Mol. Cell Biol, 29, pp.4325~4339 (2009)
  21. Struhl, K., "Histone acetylation and transcriptional regulatory mechanisms", Genes Dev, 12, pp.599~606 (1998)
  22. O'Reilly, S., "Epigenetics in fibrosis", Mol. Aspects Med, 54, pp.89~102 (2017)
  23. Bhattacharyya, S., "Egr-1 : new conductor for the tissue repair orchestra directs harmony(regeneration)or cacophony(fibrosis)", J. Pathol, 229, pp.286~297 (2013)
  24. Ghosh, A. K., "p300 is elevated in systemic sclerosis and its expression is positively regulated by TGF-beta : epigenetic feed-forward amplification of fibrosis", J. Invest. Dermatol, 133, pp.1302~1310 (2013)
  25. Rubio, K., "Inactivation of nuclear histone deacetylases by EP300 disrupts the MiCEE complex in idiopathic pulmonary fibrosis", Nat. Commun, 10, pp.2229~ (2019)
  26. 이수연, "Plumbagin Suppresses Pulmonary Fibrosis via Inhibition of p300 Histone Acetyltransferase Activity", Journal of Medicinal Food, 23(6), pp.633~640 (2020), 한국식품영양과학회[DOI]
  27. Kasper, L. H., "Conditional knockout mice reveal distinct functions for the global transcriptional coactivators CBP and p300 in T-cell development", Mol. Cell Biol, 26, pp.789~809 (2006)
  28. Park, S. Y., "Club cell-specific role of programmed cell death 5 in pulmonary fibrosis", Nat. Commun, 12, pp.2923~ (2021)
  29. Ogryzko, V. V., "The transcriptional coactivators p300 and CBP are histone acetyltransferases", Cell, 87, pp.953~959 (1996)
  30. Kuleshov, M. V., "Enrichr : a comprehensive gene set enrichment analysis web server 2016 update", Nucleic Acids Res, 44, pp.W90~W97 (2016)
  31. Cesena, T. I., "CCAAT", enhancer-binding protein(C, EBP beta at lysine 39modulates its ability to activate transcription, pp.J. Biol. Chem, 2007[DOI]
  32. Guo, L., "Transcriptional regulation of adipocyte differentiation : a central role for CCAAT", enhancer-binding protein(C, J. Biol. Chem, pp.2015, 290[DOI]
  33. Lecker, S. H., "Protein degradation by the ubiquitinproteasome pathway in normal and disease states", J. Am. Soc. Nephrol, 17, pp.1807~1819 (2006)
  34. Sahin, H., "Chemokines in tissue fibrosis", Biochim. Biophys. Acta, 1832, pp.1041~1048 (2013)
  35. King, T. E. Jr, "A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis", N. Engl. J. Med, 370, pp.2083~2092 (2014)
  36. Cottin, V., "Significance of connective tissue diseases features in pulmonary fibrosis", Eur. Respir Rev, 22, pp.273~280 (2013)
  37. Wynn, T. A, "Integrating mechanisms of pulmonary fibrosis", J. Exp. Med, 208, pp.1339~1350 (2011)
  38. Yang, J., "Diverse injury pathways induce alveolar epithelial cell CCL2", 12, which promotes lung fibrosis, 2020, pp.62, 622~632
  39. Choi, E. S., "Enhanced monocyte chemoattractant protein-3", CC chemokine ligand-7 in usual interstitial pneumonia, 2004, pp.170, 508~515
  40. Fehrenbach, H., "Alveolar epithelial type II cell : defender of the alveolus revisited", Respir. Res, 2, pp.33~46 (2001)
  41. Asahara, H., "Dual roles of p300 in chromatin assembly and transcriptional activation in cooperation with nucleosome assembly protein 1 in vitro", Mol. Cell Biol, 22, pp.2974~2983 (2002)
  42. Chan, H. M., "p300", CBP proteins : HATs for transcriptional bridges and scaffolds, 2001, pp.114, 2363~2373
  43. Lee, C. G., "Early growth response gene 1-mediated apoptosis is essential for transforming growth factor beta1-induced pulmonary fibrosis", J. Exp. Med, 200, pp.377~389 (2004)
  44. Kim, T. H., "Loss of HDAC3 results in nonreceptive endometrium and female infertility", Sci. Transl. Med, 11 (2019)[DOI]
  45. Zeng, M., "Cigarette smoke extract mediates cell premature senescence in chronic obstructive pulmonary disease patients by up-regulating USP7 to activate p300-p53", p21 pathway, 2022, pp.359, 31~45
  46. Lu, P., "De-ubiquitination of p300 by USP12 critically enhances METTL3 Expression And Ang II-induced cardiac hypertrophy", Exp. Cell Res, 406, pp.112761~ (2021)
  47. Chua, F., "Pulmonary fibrosis: searching for model answers", Am. J. Respir. Cell Mol. Biol, 33, pp.9~13 (2005)
  48. Mercer, P. F., "Pulmonary epithelium is a prominent source of proteinaseactivated receptor-1-inducible CCL2 in pulmonary fibrosis", Am. J. Resp. Crit. Care, 179, pp.414~425 (2009)
  49. Suga, M., "Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases", Eur. Respir. J, 14, pp.376~382 (1999)
  50. Baran, C. P., "Important roles for macrophage colony-stimulating factor, CC chemokine ligand 2, and mononuclear phagocytes in the pathogenesis of pulmonary fibrosis", Am. J. Respir. Crit. Care Med, 176, pp.78~89 (2007)
  51. Raghu, G., "CC-chemokine ligand 2 inhibition in idiopathic pulmonary fibrosis : a phase 2 trial of carlumab", Eur. Respir. J, 46, pp.1740~1750 (2015)
  52. Moore, B. B., "The role of CCL12 in the recruitment of fibrocytes and lung fibrosis", Am. J. Respir. Cell Mol. Biol, 35, pp.175~181 (2006)
  53. Gao, J. H., "Endothelial p300 promotes portal hypertension and hepatic fibrosis through C-C motif chemokine ligand 2-mediated angiocrine signaling", Hepatology, 73, pp.2468~2483 (2021)

관련 논문AI추천

Histone deacetylase 3 promotes alveolar epithelial–mesenchymal transition and fibroblast migration under hypoxic conditions손은숙, Jeong Sung Hwan, Kim Se-Hee, Kyung Sun Young, Lee Young Eun, Park Jeong-Woong생화학분자생물학회 · Experimental and Molecular Medicine2022 · 제54권 Therapeutic effects of selective p300 histone acetyl-transferase inhibitor on liver fibrosis박수연, 유정윤, 윤호근, Hyunsik Kim, Jae-Hwan Kwon, Mi Jeong Kim, Seunghee Byun, Soo Yeon Lee, Sungryul Yu생화학분자생물학회 · BMB Reports2023 · 제56권 제2호The role of neutrophils in the pathogenesis of IPFYangjin Jegal대한내과학회 · The Korean Journal of Internal Medicine2022 · 제37권 제5호Prolyl endopeptidase remodels macrophage function as a novel transcriptional coregulator and inhibits fibrosisCheng Yu-Qing, Chen Yuan-Wen, Ding Wen-Jin, Fan Jian-Gao, Jiang Dai-Xi, Lin Shuang-Zhe, Liu Mingxi, Ren Tian-Yi, Wu Wei-Jie, Zhang Jian-Bin생화학분자생물학회 · Experimental and Molecular Medicine2023 · 제55권 YAP1 inhibits the senescence of alveolar epithelial cells by targeting Prdx3 to alleviate pulmonary fibrosisGeng Yiding, Guo Jiayu, Guo Yingying, He Wenxin, Jin Tongzhu, Liang Haihai, Li Tianyu, Li Wenyue, Li Zhixin, Ma Lu, Ning Zhiwei, Niu Zhihui, Ren Lingxue, Shan Hongli, Sun Jian, Su Wei, Wang Qianqian, Wang Yanjie, Yang Ruoxuan, Zhang Qing, Zhang Yuhan생화학분자생물학회 · Experimental and Molecular Medicine2024 · 제56권 Loss of PCAF in proximal tubular cells exacerbates renal fibrosis by promoting partial epithelial-to-mesenchymal transitionByun Seunghee, Kim Ho-Shik, Kim Hyunseung, Kim Hyunsik, Kwon Jae-Hwan, Lee Sun-Ho, Park Soo-Yeon, Yoo Jung-Yoon, Yoon Ho-Geun생화학분자생물학회 · Experimental and Molecular Medicine2025 · 제57권

이 간행물의 다른 논문 (225건)

Endothelial senescence in vascular diseases: current understanding and future opportunities in senotherapeutics김성영, Han Yeaeunpp. 1-12Grave-to-cradle: human embryonic lineage tracing from the postmortem bodyKu Eu Jeong, Choi Seock Hwan, Choi Yujin Angelina, Oh Ji Wonpp. 13-21Chromatin and noncoding RNA-mediated mechanisms of gastric tumorigenesisKim Tae-Hee, Loe Adrian Kwan Ho, Zhu Lexinpp. 22-31TPX2 prompts mitotic survival via the induction of BCL2L1 through YAP1 protein stabilization in human embryonic stem cellsCha Hyuk-Jin, Kim Yun-Jeong, Go Young-Hyun, 정호창, Kwon Eun-Ji, Kim Seong-Min, Cheong Hyun Sub, Kim Wantae, Shin Hyoung Doo, Lee Haeseungpp. 32-42ZBTB7A suppresses glioblastoma tumorigenesis through the transcriptional repression of EPB41L5Nam Hae Yun, 김성학, 김승후, 최경철, Park Seung-Ho, Song Ji-Hye, Jeong Ji-Hoon, Kim Hyunhee, Jeong Minseok, Kong Min-Jeong, Son Jihyun, Jeong Ji-Eunpp. 43-54
원문 보기